[18F]Fludarabine-PET as a promising tool in differentiation between CNS lymphoma and glioblastoma: comparative analysis with [18F]FDG in human xenograft models.

N. Hovhannisyan; S. Guillouet; M. Dhilly; M. Ibazizene; F. Fillesoye; S. Valable; B. Plancoulaine; L. Barré

Conference papers

[18F]Fludarabine-PET as a promising tool in differentiation between CNS lymphoma and glioblastoma: comparative analysis with [18F]FDG in human xenograft models.

N. Hovhannisyan ¹ S. Guillouet ¹ M. Dhilly ¹ M. Ibazizene ¹ F. Fillesoye ¹ S. Valable ¹ B. Plancoulaine L. Barré ¹

1 ISTCT - Imagerie et Stratégies Thérapeutiques des pathologies Cérébrales et Tumorales

Document type :

Conference papers

Domain :

Life Sciences [q-bio]

Chemical Sciences

Chemical Sciences / Radiochemistry

Complete list of metadata

https://hal-normandie-univ.archives-ouvertes.fr/hal-02320429
Contributor : Carole Brunaud Connect in order to contact the contributor
Submitted on : Friday, October 18, 2019 - 4:54:37 PM
Last modification on : Wednesday, November 3, 2021 - 7:51:40 AM

[18F]Fludarabine-PET as a promising tool in differentiation between CNS lymphoma and glioblastoma: comparative analysis with [18F]FDG in human xenograft models.

Identifiers

Collections

Citation

Export

Metrics

14

[18F]Fludarabine-PET as a promising tool in differentiation between CNS lymphoma and glioblastoma: comparative analysis with [18F]FDG in human xenograft models.

Identifiers

Collections

Citation

Export

Share

Metrics

14